Verona Pharma PLC ADR Cash Flow-to-Debt Ratio
Verona Pharma PLC ADR cash flow-to-debt ratio. Verona Pharma PLC ADR (VRNA) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2025, meaning its operating cash flow of $30.56 Million could theoretically repay 0% of its total liabilities ($294.60 Million) in one year. Check Verona Pharma PLC ADR (VRNA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Verona Pharma PLC ADR (2005–2024)
Cash flow-to-debt ratio of Verona Pharma PLC ADR from 2005 to 2024. Historical debt coverage capacity for Verona Pharma PLC ADR across 20 annual periods. Check Verona Pharma PLC ADR earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Verona Pharma PLC ADR Cash Flow-to-Debt Ratio by Year (2005–2024)
Verona Pharma PLC ADR cash flow-to-debt ratio by year from 2005 to 2024. Year-by-year debt coverage analysis for Verona Pharma PLC ADR. For the full cash flow conversion analysis, see how efficiently does Verona Pharma PLC ADR generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.45x | $-122.20 Million | $269.68 Million | ▲ +46.9% |
| 2023 | -0.85x | $-50.22 Million | $58.84 Million | ▲ +58.6% |
| 2022 | -2.06x | $-59.86 Million | $29.00 Million | ▼ -139.5% |
| 2021 | -0.86x | $-33.25 Million | $38.58 Million | ▲ +63.0% |
| 2020 | -2.33x | $-45.08 Million | $19.35 Million | ▲ +22.4% |
| 2019 | -3.00x | $-44.34 Million | $14.78 Million | ▼ -87.7% |
| 2018 | -1.60x | $-22.98 Million | $14.37 Million | ▲ +25.7% |
| 2017 | -2.15x | $-27.97 Million | $13.00 Million | ▼ -349.3% |
| 2016 | -0.48x | $-6.89 Million | $14.40 Million | ▲ +86.3% |
| 2015 | -3.50x | $-9.41 Million | $2.69 Million | ▲ +48.1% |
| 2014 | -6.75x | $-5.51 Million | $816.08K | ▼ -60.8% |
| 2013 | -4.20x | $-3.39 Million | $806.89K | ▲ +66.9% |
| 2012 | -12.67x | $-4.08 Million | $322.11K | ▼ -25.6% |
| 2011 | -10.09x | $-2.44 Million | $242.21K | ▼ -25.2% |
| 2010 | -8.06x | $-2.56 Million | $317.94K | ▼ -42.8% |
| 2009 | -5.64x | $-2.62 Million | $464.08K | ▲ +64.9% |
| 2008 | -16.07x | $-1.98 Million | $123.01K | ▼ -109.4% |
| 2007 | -7.68x | $-2.39 Million | $311.35K | ▼ -44.3% |
| 2006 | -5.32x | $-687.68K | $129.31K | ▼ -3290.9% |
| 2005 | 0.17x | $3.44K | $20.65K | — |